EXEL Price / Book | Exelixis Inc

Exelixis Inc (EXEL) Price / Book

2026-09-03: Price/Book Ratio 7.95.
2026-07-03: Price/Book Ratio 7.54.
2026-04-03: Price/Book Ratio 5.75.
2026-01-02: Price/Book Ratio 5.29.

Historical market capitalization divided by filed shareholder equity.

Available history: 2011-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	7.95
2026-07-03	7.54
2026-04-03	5.75
2026-01-02	5.29
2025-10-03	4.97
2025-07-04	6.13
2025-04-04	4.46
2025-01-03	4.26
2024-09-27	3.26
2024-06-28	3.02
2024-03-29	3.29
2023-12-29	3.21
2023-09-29	2.89
2023-06-30	2.42
2023-03-31	2.47
2022-12-30	2.09
2022-09-30	2.03
2022-07-01	2.9
2022-04-01	3.2
2021-12-31	2.64
2021-10-01	3.23
2021-07-02	2.81
2021-04-02	3.79
2021-01-01	3.33
2020-10-02	3.91
2020-07-03	3.96
2020-04-03	2.89
2020-01-03	3.08
2019-09-27	3.41
2019-06-28	4.35
2019-03-29	5.18
2018-12-28	4.53
2018-09-28	5.78
2018-06-29	8.27
2018-03-30	9.8
2017-12-31	31.6
2017-12-29	31.6
2017-09-30	30.01
2017-06-30	48.71
2017-03-31	52.9
2016-12-31	48.4
2016-12-30	48.4
2016-09-30	114.28
2014-06-30	203.93
2014-03-31	9.64
2013-12-31	78.02
2013-09-30	8.07
2013-06-30	4.26
2013-03-31	3.33
2012-12-31	3.53
2012-09-30	2.6
2012-06-30	8.31
2012-03-31	5.81
2011-12-31	7.09
2011-09-30	230.58

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78